Medilente Pharma Private Limited - Company Profile

It is a pharma private limited company based in Chandigarh, Chandigarh, India, established in 2013.
2013 Chandigarh, Chandigarh, India Active
Last Updated:
Access Report
About Medilente Pharma Private Limited

Medilente Pharma Private Limited, a active private limited company, was established on 12 June 2013 in Chandigarh, Chandigarh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232CH2013PTC034546. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹0.30 M and a paid-up capital of ₹0.30 M.

It upholds a compliant status. Its leadership includes Pragya Sharma (Director), Rohtas Sharma (Director), Nikhil Sharma (Additional Director). Past directors included Dharinder Vashishta, Rahul Rawat. It holds ₹1.80 Cr open charges and ₹4.50 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No.176 Industrial Business Park, Phase-1, Chandigarh, Chandigarh, 160002.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232CH2013PTC034546

  • Registration Number

    034546

  • Incorporation Date

    12 June 2013

  • Authorized Capital

    ₹0.30 M

  • Paid-Up Capital

    ₹0.30 M

  • ROC Code

    Roc Chandigarh

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.30 M
  • Paid Up Capital ₹ 0.30 M
  • Company Age 12 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 1.80 Cr
  • Satisfied Charges ₹ 4.50 M
  • Revenue Growth **** -37.33%
  • Profit Growth **** 8.12%
  • Ebitda **** -33.77%
  • Net Worth 22.56%
  • Total Assets -2.02%
Company report

Medilente Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Medilente Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Medilente Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Pragya Sharma Director 12 Jun 2013 Current
Rohtas Sharma Director 21 Jan 2023 Current
Nikhil Sharma Additional Director 23 Apr 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 03 Jul 2015 Past
Pramod Abcsdd Additional Director 30 Sep 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Medilente Pharma.

Medilente Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 37.33% decrease. The company also saw a slight improvement in profitability, with a 8.12% increase in profit. The company's net worth Soared by an impressive increase of 22.56%.

Medilente Pharma revenue growth over time
Medilente Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -37.33%
*******
*******
*******
*******
Revenue from Operations
*******
 -36.67%
*******
*******
*******
*******
Total Assets
*******
 -2.02%
*******
*******
*******
*******
Profit or Loss
*******
 8.12%
*******
*******
*******
*******
Net Worth
*******
 22.56%
*******
*******
*******
*******
EBITDA
*******
 -33.77%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Medilente Pharma?

In 2023, Medilente Pharma had a public holding of 56.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹18,000,000.00

Satisfied Charges

₹4,500,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 1.00 Cr
  • Canara Bank : 0.80 Cr
Latest Charge Details
Date Lender Amount Status
11 Dec 2025 Hdfc Bank Limited ₹1.00 Cr Open
13 Dec 2024 Canara Bank ₹8.00 M Open
16 Jun 2023 Hdfc Bank Limited ₹4.50 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Medilente Pharma?

Unlock and access historical data on people associated with Medilente Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Medilente Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medilente Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Medilente Pharma
Recent Activity within the Organization
  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 10.00 M with Charge ID 101203810 was registered on 11 Dec 2025. was documented.

  • Annual General Meeting

    The activity Medilente Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Medilente Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh. was completed.

  • Charges

    The activity A charge registered on 16 Jun 2023 via Charge ID 100780094 with Hdfc Bank Limited was fully satisfied on 03 Jan 2025. was completed.

  • Charges

    Progress on A charge with Canara Bank amounted to Rs. 8.00 M with Charge ID 101032524 was registered on 13 Dec 2024. was documented.

  • Director Appointment

    Nikhil Sharma was appointed as a Additional Director was appointed as a Additional Director on 23 Apr 2024 & has been associated with this company since 1 year 9 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Medilente Pharma Private Limited?

The CIN of Medilente Pharma Private Limited is U24232CH2013PTC034546.

Where is Medilente Pharma Private Limited headquartered?

Medilente Pharma Private Limited is headquartered at Plot No.176 Industrial Business Park, Phase-1, Chandigarh, Chandigarh, 160002.

When was Medilente Pharma Private Limited incorporated?

Medilente Pharma Private Limited was incorporated on 12 June 2013.

Who are the current directors of Medilente Pharma Private Limited?

The current directors of Medilente Pharma Private Limited are

What is the primary industry of Medilente Pharma Private Limited?

The primary industry of Medilente Pharma Private Limited is Manufacturing.

Is Medilente Pharma Private Limited a listed company?

Medilente Pharma Private Limited is unlisted.

What is the capital structure of Medilente Pharma Private Limited?

The authorized capital of Medilente Pharma Private Limited is ₹0.30 M, and the paid-up capital is ₹0.30 M.

What is the compliance status of Medilente Pharma Private Limited?

The compliance status of Medilente Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available